Your Complete Guide to Choosing the Right Treatment Online
Mounjaro vs Wegovy vs Ozempic: Online Prescription Made Simple
Getting prescribed Mounjaro, Wegovy or Ozempic online removes the traditional barriers of GP waiting lists and specialist referrals. Our 3-minute clinical assessment evaluates your suitability for each treatment, considering factors like your BMI, medical history and current medications. Licensed UK prescribers review every application within 3 working days (or 24 hours with express service), determining which of these prescription-only medicines aligns best with your individual circumstances. The online process ensures you receive the same clinical oversight as traditional healthcare settings, but with the convenience of accessing treatment from home.
When comparing Mounjaro vs Wegovy vs Ozempic for online prescription, it's important to understand that each requires specific clinical criteria to be met. Wegovy and Mounjaro are both licensed for weight management in adults with BMI ≥30, or BMI ≥27 with weight-related comorbidities. Ozempic, however, is licensed specifically for type 2 diabetes management, though it contains the same active ingredient as Wegovy. Our prescribers ensure you're matched with the appropriate treatment based on your medical profile and licensed indications.
Pricing Comparison: Mounjaro vs Wegovy vs Ozempic Costs
Understanding the cost implications of Mounjaro vs Wegovy vs Ozempic helps inform your treatment decision alongside clinical considerations. Wegovy pricing starts at £79.99 for the 0.25mg starter dose, progressing to £94.99 (0.5mg), £99.99 (1mg), £139.99 (1.7mg), and £209.99 for the 2.4mg maintenance dose. Our bundle options provide convenience for multiple doses, such as the Intro Duo (0.25mg & 0.5mg) for £169.99. New customers apply discount code FIRST40 at checkout to reach these final prices, whilst returning customers use code DOSE25.
Mounjaro and Ozempic have different pricing structures that our prescribers will discuss during your consultation. All three treatments represent a significant investment in your health journey, which is why our clinical team ensures you understand the dose escalation timeline and total treatment costs upfront. The online prescription process eliminates additional consultation fees that traditional clinics often charge, making these treatments more accessible through our transparent pricing model.
Clinical Evidence: How Mounjaro vs Wegovy vs Ozempic Compare
The clinical evidence supporting Mounjaro vs Wegovy vs Ozempic demonstrates distinct mechanisms of action that may suit different patient profiles. Wegovy (semaglutide) showed an average of ~clinically studied weight loss at 68 weeks in the STEP 1 trial (Wilding et al., NEJM, 2021), whilst patients taking placebo achieved ~clinically studied weight loss alongside diet and exercise. The STEP programme also demonstrated sustained results, with STEP 5 showing ~clinically studied weight loss maintained at 2 years.
Mounjaro (tirzepatide) operates as a dual GIP and GLP-1 receptor agonist, potentially offering different appetite regulation compared to Wegovy's GLP-1-only mechanism. Clinical trials suggest Mounjaro may support different weight loss patterns, though direct head-to-head comparisons between Mounjaro vs Wegovy vs Ozempic should be interpreted carefully due to varying trial designs and patient populations. Both Wegovy and Mounjaro are available from EverydayMeds — your prescriber can help determine which clinical profile matches your individual circumstances.
How These Weight Management Treatments Work
Understanding the mechanisms behind Mounjaro vs Wegovy vs Ozempic helps explain why different patients may respond better to specific treatments. Wegovy contains semaglutide, a GLP-1 receptor agonist that mimics a natural fullness hormone produced in your intestines. This medication works on brain appetite centres to reduce hunger signals and promote feelings of satiety after smaller meals, potentially reducing food cravings throughout the day. The once-weekly injection via FlexTouch pen provides consistent medication levels, supporting appetite regulation alongside a reduced-calorie diet and increased physical activity. Patients often report feeling satisfied with smaller portions and experiencing fewer food thoughts between meals.
Online Prescription Process: From Assessment to Delivery
Our streamlined online prescription process for Mounjaro vs Wegovy vs Ozempic takes just 3 minutes to complete, covering essential medical history, current medications, and weight management goals. The clinical assessment includes BMI calculations, screening for contraindications, and evaluation of previous weight management attempts to ensure appropriate treatment selection. Licensed UK prescribers review every application individually, with standard approval taking 3 working days or express 24-hour service for faster access. Once approved, your chosen medication ships via next-day delivery in temperature-controlled packaging, maintaining the cold-chain integrity essential for these biological medications. No GP appointment or specialist referral is required, removing traditional healthcare barriers whilst maintaining clinical safety standards.
Storage and Practical Considerations
Practical differences between Mounjaro vs Wegovy vs Ozempic include storage requirements that may influence your treatment choice. Wegovy offers superior travel convenience, remaining stable at room temperature (below 30°C) for up to 6 weeks once removed from refrigeration, compared to Mounjaro's 21-day room temperature limit. All unopened pens require refrigeration at 2-8°C before first use, fitting easily in standard home refrigerators. The FlexTouch pen system used by Wegovy provides pre-filled, single-use injections with dose escalation built into the treatment timeline. Patients progress through 0.25mg, 0.5mg, 1mg, 1.7mg, and 2.4mg doses over 17 weeks, with each dose level designed to optimise tolerance whilst building therapeutic effectiveness. The weekly injection schedule fits easily into most routines, with patients often choosing the same day each week for consistency.
Choosing Between Mounjaro vs Wegovy vs Ozempic for Online Treatment
The decision between Mounjaro vs Wegovy vs Ozempic for online prescription depends on individual medical factors that our clinical assessment evaluates comprehensively. Patients with type 2 diabetes may find Ozempic addresses both glucose management and weight-related goals, whilst those focused primarily on weight management might consider Wegovy or Mounjaro. The dual-agonist mechanism of Mounjaro offers a different approach to appetite regulation compared to Wegovy's GLP-1-only action, potentially suiting patients who haven't achieved desired results with other treatments.
Our online prescription service removes the guesswork by matching your medical profile with the most appropriate treatment option. Licensed prescribers consider factors including previous medication responses, lifestyle requirements, and medical history to recommend between Mounjaro vs Wegovy vs Ozempic. This personalised approach ensures you start with the treatment most likely to support your individual weight management goals, backed by clinical oversight throughout your journey.
Start Your Treatment Journey Today
Ready to discover which option in the Mounjaro vs Wegovy vs Ozempic comparison suits your needs? Our 3-minute online assessment begins your journey toward clinically-supported weight management, with new customers using code FIRST40 and returning customers applying DOSE25 at checkout. Licensed UK prescribers will review your application and recommend the most suitable treatment based on your individual circumstances. Visit https://everydaymeds.co.uk/collections/wegovy to begin your clinical assessment today. Both Wegovy and Mounjaro are available from EverydayMeds — your prescriber can help determine which is right for you. Our GPhC-registered pharmacy (#9012878) ensures you receive genuine, properly stored medications with the clinical support needed for successful weight management.
Reviewed by the EverydayMeds Clinical Team · GPhC #9012878 · Last updated February 2026
